82 related articles for article (PubMed ID: 18536190)
21. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
Shan BE; Wang MX; Li RQ
Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
[TBL] [Abstract][Full Text] [Related]
22. Vinorelbine induces beta3-tubulin gene expression through an AP-1 Site.
Saussede-Aim J; Matera EL; Herveau S; Rouault JP; Ferlini C; Dumontet C
Anticancer Res; 2009 Aug; 29(8):3003-9. PubMed ID: 19661308
[TBL] [Abstract][Full Text] [Related]
23. Activation of the mitochondria-driven pathway of apoptosis in human PC-3 prostate cancer cells by a novel hydrophilic paclitaxel derivative, 7-xylosyl-10-deacetylpaclitaxel.
Jiang S; Zu Y; Fu Y; Zhang Y; Efferth T
Int J Oncol; 2008 Jul; 33(1):103-11. PubMed ID: 18575755
[TBL] [Abstract][Full Text] [Related]
24. Apple polyphenol phloretin potentiates the anticancer actions of paclitaxel through induction of apoptosis in human hep G2 cells.
Yang KC; Tsai CY; Wang YJ; Wei PL; Lee CH; Chen JH; Wu CH; Ho YS
Mol Carcinog; 2009 May; 48(5):420-31. PubMed ID: 18767070
[TBL] [Abstract][Full Text] [Related]
25. Molecular response of HL-60 cells to mitotic inhibitors vincristine and taxol visualized with apoptosis-related gene expressions, including the new member BCL2L12.
Thomadaki H; Floros KV; Scorilas A
Ann N Y Acad Sci; 2009 Aug; 1171():276-83. PubMed ID: 19723066
[TBL] [Abstract][Full Text] [Related]
26. Gene expression changes during the development of estrogen-independent and antiestrogen-resistant growth in breast cancer cell culture models.
Pennanen PT; Sarvilinna NS; Ylikomi TJ
Anticancer Drugs; 2009 Jan; 20(1):51-8. PubMed ID: 19343000
[TBL] [Abstract][Full Text] [Related]
27. [Study on apoptosis of human stomach SGC-7901 cells induced by extracts of Solanum lyratum].
Wan FS; Wu J; Li H; Tu S; Yu LH
Zhong Yao Cai; 2009 Feb; 32(2):245-9. PubMed ID: 19504972
[TBL] [Abstract][Full Text] [Related]
28. Genistein induces cell apoptosis in MDA-MB-231 breast cancer cells via the mitogen-activated protein kinase pathway.
Li Z; Li J; Mo B; Hu C; Liu H; Qi H; Wang X; Xu J
Toxicol In Vitro; 2008 Oct; 22(7):1749-53. PubMed ID: 18761399
[TBL] [Abstract][Full Text] [Related]
29. Emodin sensitizes paclitaxel-resistant human ovarian cancer cells to paclitaxel-induced apoptosis in vitro.
Li J; Liu P; Mao H; Wanga A; Zhang X
Oncol Rep; 2009 Jun; 21(6):1605-10. PubMed ID: 19424643
[TBL] [Abstract][Full Text] [Related]
30. Expression of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) in HCC70 breast cancer cells and effects of treatment with gonadotropin-releasing hormone on RANKL expression.
Schubert A; Schulz H; Emons G; Gründker C
Gynecol Endocrinol; 2008 Jun; 24(6):331-8. PubMed ID: 18584413
[TBL] [Abstract][Full Text] [Related]
31. The use of genomic tools for the molecular understanding of breast cancer and to guide personalized medicine.
Foekens JA; Wang Y; Martens JW; Berns EM; Klijn JG
Drug Discov Today; 2008 Jun; 13(11-12):481-7. PubMed ID: 18549973
[TBL] [Abstract][Full Text] [Related]
32. Gene expression of the invasive phenotype of TNF-alpha-treated MCF-7 cells.
Yin Y; Chen X; Shu Y
Biomed Pharmacother; 2009 Jul; 63(6):421-8. PubMed ID: 19564093
[TBL] [Abstract][Full Text] [Related]
33. Calcium sensing receptor down-regulates malignant cell behavior and promotes chemosensitivity in human breast cancer cells.
Liu G; Hu X; Chakrabarty S
Cell Calcium; 2009 Mar; 45(3):216-25. PubMed ID: 19038444
[TBL] [Abstract][Full Text] [Related]
34. An association between clusterin over-expression and taxol-resistance in ovarian cancer.
Hassan MK
Hokkaido Igaku Zasshi; 2008 Sep; 83(5):335-46. PubMed ID: 18946958
[No Abstract] [Full Text] [Related]
35. Paclitaxel-doxorubicin sequence is more effective in breast cancer cells with heat shock protein 27 overexpression.
Shi P; Wang MM; Jiang LY; Liu HT; Sun JZ
Chin Med J (Engl); 2008 Oct; 121(20):1975-9. PubMed ID: 19080259
[TBL] [Abstract][Full Text] [Related]
36. 3-D tumor model for in vitro evaluation of anticancer drugs.
Horning JL; Sahoo SK; Vijayaraghavalu S; Dimitrijevic S; Vasir JK; Jain TK; Panda AK; Labhasetwar V
Mol Pharm; 2008; 5(5):849-62. PubMed ID: 18680382
[TBL] [Abstract][Full Text] [Related]
37. TIMP-1 overexpression promotes tumorigenesis of MDA-MB-231 breast cancer cells and alters expression of a subset of cancer promoting genes in vivo distinct from those observed in vitro.
Bigelow RL; Williams BJ; Carroll JL; Daves LK; Cardelli JA
Breast Cancer Res Treat; 2009 Sep; 117(1):31-44. PubMed ID: 18787947
[TBL] [Abstract][Full Text] [Related]
38. Microarray-based gene expression profiling as a clinical tool for breast cancer management: are we there yet?
Correa Geyer F; Reis-Filho JS
Int J Surg Pathol; 2009 Aug; 17(4):285-302. PubMed ID: 19103611
[TBL] [Abstract][Full Text] [Related]
39. Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers.
Tanei T; Morimoto K; Shimazu K; Kim SJ; Tanji Y; Taguchi T; Tamaki Y; Noguchi S
Clin Cancer Res; 2009 Jun; 15(12):4234-41. PubMed ID: 19509181
[TBL] [Abstract][Full Text] [Related]
40. Let-7a microRNA suppresses therapeutics-induced cancer cell death by targeting caspase-3.
Tsang WP; Kwok TT
Apoptosis; 2008 Oct; 13(10):1215-22. PubMed ID: 18758960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]